1
|
Sumphanapai T, Chester K, Sawatnatee S, Yeung J, Yamabhai M. Targeting acute myeloid cell surface using a recombinant antibody isolated from whole-cell biopanning of a phage display human scFv antibody library. MEDICAL ONCOLOGY (NORTHWOOD, LONDON, ENGLAND) 2022; 39:205. [PMID: 36175701 DOI: 10.1007/s12032-022-01806-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/07/2022] [Accepted: 07/20/2022] [Indexed: 11/27/2022]
Abstract
To discover new therapeutic antibodies for treatment of acute myeloid leukemia (AML) without the requirement of a known antigen, a human single-chain variable fragment (scFv) library was used to isolate novel antibody fragments recognizing HL-60 AML cells. After three rounds of biopanning, scFv-expressing phages were selected to test for binding to the target cell by flow cytometry. The clone with highest binding specificity to HL-60 cells (designated y1HL63D6) was further investigated. Fluorescent staining indicated that y1HL63D6 scFv bound to a target located on the cell surface. Whole immunoglobulin, IgG-y1HL63D6 was then generated and tested for the binding against bone marrow mononuclear cells (BMMCs) from AML patients. Significantly higher fluorescent signals were observed for some patient samples when compared to normal BMMCs or non-AML patients' BMMCs. Next, the IgG-y1HL63D6 format was tested for antibody-dependent cell cytotoxicity (ADCC). The results demonstrated that IgG-y1HL63D6 but not the control antibody, trastuzumab, could mediate specific killing of HL-60 target cells. In conclusion, our results indicate that specific antibodies can be isolated by biopanning whole cells with a non-immunized human scFv antibody phage display library and that the isolated antibody against HL-60 cells showed therapeutic potential.
Collapse
Affiliation(s)
- Thitima Sumphanapai
- Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, 111 University Avenue, Nakhon Ratchasima, 30000, Thailand
| | - Kerry Chester
- University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK
| | - Surasak Sawatnatee
- Hematology Unit, Sunpasitthiprasong Hospital, Ubon Ratchathani, 34000, Thailand
| | - Jenny Yeung
- University College London Cancer Institute, 72 Huntley Street, London, WC1E 6BT, UK
- University College London Great Ormond Street Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK
| | - Montarop Yamabhai
- Molecular Biotechnology Laboratory, School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, 111 University Avenue, Nakhon Ratchasima, 30000, Thailand.
| |
Collapse
|
2
|
Takagi‐Maeda S, Yajima S, Suzuki T, Usami K, Takahashi N, Niwa R, Shimada H. A novel cancer‐specific EGFR antibody obtained from the serum of esophageal cancer patients with long‐term survival. Cancer Sci 2022; 113:2118-2128. [PMID: 35348270 PMCID: PMC9207364 DOI: 10.1111/cas.15350] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2021] [Revised: 03/15/2022] [Accepted: 03/22/2022] [Indexed: 12/09/2022] Open
Affiliation(s)
- Sayaka Takagi‐Maeda
- Research and Development Division Kyowa Kirin Co., Ltd. 3‐6‐6 Asahi‐machi, Machida‐shi Tokyo 194‐8533 Japan
| | - Satoshi Yajima
- Department of Surgery School of Medicine Toho University 6‐11‐1 Omori‐Nishi, Ota‐ku Tokyo 143‐8541 Japan
| | - Takashi Suzuki
- Department of Surgery School of Medicine Toho University 6‐11‐1 Omori‐Nishi, Ota‐ku Tokyo 143‐8541 Japan
| | - Katsuaki Usami
- Research and Development Division Kyowa Kirin Co., Ltd. 3‐6‐6 Asahi‐machi, Machida‐shi Tokyo 194‐8533 Japan
| | - Nobuaki Takahashi
- Research and Development Division Kyowa Kirin Co., Ltd. 1‐9‐2 Otemachi, Chiyoda‐ku Tokyo 100‐0004 Japan
| | - Rinpei Niwa
- Research and Development Division Kyowa Kirin Co., Ltd. 3‐6‐6 Asahi‐machi, Machida‐shi Tokyo 194‐8533 Japan
| | - Hideaki Shimada
- Department of Surgery School of Medicine Toho University 6‐11‐1 Omori‐Nishi, Ota‐ku Tokyo 143‐8541 Japan
- Department of Gastroenterological Surgery and Clinical Oncology Toho University Graduate School of Medicine 6‐11‐1, Omori‐Nishi, Ota‐ku Tokyo 143‐8541 Japan
| |
Collapse
|
3
|
Rafique A, Satake K, Kishimoto S, Hasan Khan K, Kato DI, Ito Y. Efficient Screening and Design of Variable Domain of Heavy Chain Antibody Ligands Through High Throughput Sequencing for Affinity Chromatography to Purify Fab Fragments. Monoclon Antib Immunodiagn Immunother 2019; 38:190-200. [DOI: 10.1089/mab.2019.0027] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Abdur Rafique
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan
| | - Kiriko Satake
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan
| | - Satoshi Kishimoto
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan
| | - Kamrul Hasan Khan
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan
| | - Dai-ichiro Kato
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan
| | - Yuji Ito
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, University of Kagoshima, Kagoshima, Japan
| |
Collapse
|
4
|
Muchima K, Todaka T, Shinchi H, Sato A, Tazoe A, Aramaki R, Kakitsubata Y, Yokoyama R, Arima N, Baba M, Wakao M, Ito Y, Suda Y. Development of sugar chain-binding single-chain variable fragment antibody to adult T-cell leukemia cells using glyco-nanotechnology and phage display method. J Biochem 2018; 163:281-291. [PMID: 29351623 DOI: 10.1093/jb/mvy005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2017] [Accepted: 10/06/2017] [Indexed: 11/12/2022] Open
Abstract
Adult T-cell leukemia (ATL) is an intractable blood cancer caused by the infection of human T-cell leukemia virus type-1, and effective medical treatment is required. It is known that the structure and expression levels of cell surface sugar chains vary depending on cell states such as inflammation and cancer. Thus, it is expected that the antibody specific for ATL cell surface sugar chain would be an effective diagnostic tool and a strong candidate for the development of an anti-ATL drug. Here, we developed a stable sugar chain-binding single-chain variable fragment antibody (scFv) that can bind to ATL cells using a fibre-type Sugar Chip and phage display method. The fiber-type Sugar Chips were prepared using O-glycans released from ATL cell lines. The scFv-displaying phages derived from human B cells (diversity: 1.04 × 108) were then screened using the fiber-type Sugar Chips, and an O-glycan-binding scFv was obtained. The flow cytometry analysis revealed that the scFv predominantly bound to ATL cell lines. The sugar chain-binding properties of the scFv was evaluated by array-type Sugar Chip immobilized with a library of synthetic glycosaminoglycan disaccharide structures. Highly sulphated disaccharide structures were found to have high affinity to scFv.
Collapse
Affiliation(s)
- Kaname Muchima
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Taro Todaka
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Hiroyuki Shinchi
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Ayaka Sato
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Arisa Tazoe
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Rikiya Aramaki
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Yuhei Kakitsubata
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Risa Yokoyama
- Graduate School of Medical and Dental Sciences, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima 890-8544, Japan
| | - Naomichi Arima
- SUDx-Biotec Corporation, Shiroyama 1-21-40, Kagoshima 890-0013, Japan
| | - Masanori Baba
- SUDx-Biotec Corporation, Shiroyama 1-21-40, Kagoshima 890-0013, Japan
| | - Masahiro Wakao
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Yuji Ito
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan
| | - Yasuo Suda
- Graduate School of Science and Engineering, Kagoshima University, 1-21-40 Kohrimoto, Kagoshima 890-0065, Japan.,Graduate School of Medical and Dental Sciences, Kagoshima University, Sakuragaoka 8-35-1, Kagoshima 890-8544, Japan
| |
Collapse
|
5
|
Ito Y. Development of a Rapid Identification Method for a Variety of Antibody Candidates Using High-throughput Sequencing. YAKUGAKU ZASSHI 2017; 137:823-830. [PMID: 28674295 DOI: 10.1248/yakushi.16-00252-2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
As an alternative to hybridoma technology, the antibody phage library system can also be used for antibody selection. This method enables the isolation of antigen-specific binders through an in vitro selection process known as biopanning. While it has several advantages, such as an avoidance of animal immunization, the phage cloning and screening steps of biopanning are time-consuming and problematic. Here, we introduce a novel biopanning method combined with high-throughput sequencing (HTS) using a next-generation sequencer (NGS) to save time and effort in antibody selection, and to increase the diversity of acquired antibody sequences. Biopannings against a target antigen were performed using a human single chain Fv (scFv) antibody phage library. VH genes in pooled phages at each round of biopanning were analyzed by HTS on a NGS. The obtained data were trimmed, merged, and translated into amino acid sequences. The frequencies (%) of the respective VH sequences at each biopanning step were calculated, and the amplification factor (change of frequency through biopanning) was obtained to estimate the potential for antigen binding. A phylogenetic tree was drawn using the top 50 VH sequences with high amplification factors. Representative VH sequences forming the cluster were then picked up and used to reconstruct scFv genes harboring these VHs. Their derived scFv-Fc fusion proteins showed clear antigen binding activity. These results indicate that a combination of biopanning and HTS enables the rapid and comprehensive identification of specific binders from antibody phage libraries.
Collapse
Affiliation(s)
- Yuji Ito
- Department of Chemistry and Bioscience, Graduate School of Science and Engineering, Kagoshima University
| |
Collapse
|
6
|
Miyazaki N, Kiyose N, Akazawa Y, Takashima M, Hagihara Y, Inoue N, Matsuda T, Ogawa R, Inoue S, Ito Y. Isolation and characterization of antigen-specific alpaca (Lama pacos) VHH antibodies by biopanning followed by high-throughput sequencing. J Biochem 2015; 158:205-15. [DOI: 10.1093/jb/mvv038] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2014] [Accepted: 02/17/2015] [Indexed: 01/28/2023] Open
|
7
|
Rich RL, Myszka DG. Survey of the 2009 commercial optical biosensor literature. J Mol Recognit 2012; 24:892-914. [PMID: 22038797 DOI: 10.1002/jmr.1138] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
We took a different approach to reviewing the commercial biosensor literature this year by inviting 22 biosensor users to serve as a review committee. They set the criteria for what to expect in a publication and ultimately decided to use a pass/fail system for selecting which papers to include in this year's reference list. Of the 1514 publications in 2009 that reported using commercially available optical biosensor technology, only 20% passed their cutoff. The most common criticism the reviewers had with the literature was that "the biosensor experiments could have been done better." They selected 10 papers to highlight good experimental technique, data presentation, and unique applications of the technology. This communal review process was educational for everyone involved and one we will not soon forget.
Collapse
Affiliation(s)
- Rebecca L Rich
- Center for Biomolecular Interaction Analysis, University of Utah, Salt Lake City, UT, USA
| | | |
Collapse
|
8
|
Maeda M, Ito Y, Hatanaka T, Hashiguchi S, Torikai M, Nakashima T, Sugimura K. Regulation of T cell response by blocking the ICOS signal with the B7RP-1-specific small antibody fragment isolated from human antibody phage library. MAbs 2009; 1:453-61. [PMID: 20065650 DOI: 10.4161/mabs.1.5.9633] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
A costimulatory signal is required for the full activation of T cells, in addition to the antigen-specific signal via the T cell receptor. The inducible costimulator, ICOS is one of the costimulatory molecules that play an essential role in this process, particularly in the expansion or the development of effector T cells. As blocking of the interaction between ICOS and its ligand, B7RP-1, suppresses the T cell response, it can be applied to the treatment of allograft rejection or autoimmune diseases. Here, we isolated four scFv clones that were specific to human B7RP-1 by biopanning a human antibody phage library. We found that three of these clones inhibited the interaction between ICOS-Fc and B7RP-1-Fc. These inhibitory clones not only recognized B7RP-1 molecules expressed on B cells, as assessed by FACS, but also exhibited inhibitory activity in a proliferation assay of T cells stimulated with anti-CD3 mAb and B7RP-1-Fc. Finally, the suppression effect of the scFv on the allogenic immune response was examined using a mixed lymphocyte reaction assay, which demonstrated a successful inhibition of the allogenic reaction, in spite of the high dose needed for complete inhibition (360 nM).
Collapse
Affiliation(s)
- Masatoshi Maeda
- Department of Chemistry, Biotechnology and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, Kagoshima, Kagoshima, Japan
| | | | | | | | | | | | | |
Collapse
|